Clinical Trial Update: A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whole-brain radiotherapy with concurrent temozolomide versus hippocampal avoidance in patients with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Brain Metastasis, Radiation Therapy Complication | Phase 2 | Status: UNKNOWN